AACR Results Of Single Agent Ibrutinib from Dr... - CLL Support

CLL Support

22,493 members38,640 posts

AACR Results Of Single Agent Ibrutinib from Dr. Wiestner of the NIH

bkoffman profile image
bkoffmanCLL CURE Hero
0 Replies

The press release of Dr. Wiestner of the NIH on the one year data on single agent ibrutinib with no other drugs to help in 17p del and > 65 patients, with my commentary: bkoffman.blogspot.com/2013/...

Bottom line: 94% event free survival at one year. WOW!

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...

You may also like...

Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studies

the first year of ibrutinib and does not preclude extended therapy. Lots to read here:...

Vaccines, Ibrutinib toxicity,Dr. Rai on a cure, Dr Ghia on TP563 testing and ERIC

org/2019/10/vaccines-for-cll-patients/ Dr. Awan wrote for us on the recent news about Ibrutinib's...

Is there withdrawal from stopping ibrutinib?

Dr wanted me off ibrutinib for a couple months before possibly starting alacabrutinib. Having...

Encouraging results from son of Ibrutinib studies (Acalabrutinib/Calquence)

results of a drug which all being well may one day replace ibrutinib. Not every promising drug...

Ibrutinib – Results after 10 Months

on my results on Ibrutinib after 10 months of treatment for those starting Ibrutinib. I’m 61,...